Breast Cancer
Conditions
Interventions
Experimental group:None
Control group:none
Sponsors
West China Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Gender and age are not limited; 2. The experimental group was patients with breast cancer diagnosed by pathology who had taken antihypertensive, lipid-lowering or antiplatelet drugs for a long time; 3. No concurrent use of drugs other than antihypertensive, lipid-lowering, antiplatelet drugs, chemotherapy, and targeted therapy drugs; 4. The control group was diagnosed as breast cancer by pathology without other chronic diseases; 5. No other drugs besides chemotherapy and targeted therapy were taken simultaneously in the control group;
Exclusion criteria
Exclusion criteria: 1. Breast cancer patients without pathological diagnosis; 2. In addition to patients with primary hypertension, hyperlipidemia, coronary heart disease, and other severe heart diseases in the experimental group; 3. Simultaneously accompanied by other internal medicine diseases; 4. Patients with severe systemic infections; 5. Patients with immune suppression or other serious illnesses; 6. Patients with related blood system diseases (including anemia, hemophilia, primary thrombocytosis, etc.); 7. Patients with multiple malignant tumors or previous malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence and metastasis;survival time ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Baseline data (including age, sex, comorbid diseases, lesion location, molecular typing, pathological type, etc.);Postoperative complications;Total postoperative hospital stay;Types of antihypertensive, lipid-lowering or antiplatelet drugs;Time of administration; | — |
Countries
China
Contacts
Public ContactJie Chen
West China Hospital
Outcome results
None listed